Advertisement

Internal Medicine

Home Internal Medicine
Coagadex (coagulation Factor X) has been approved by the U.S. Food and Drug Administration as the first coagulation factor replacement therapy for people with a rare blood disorder known as hereditary Factor X deficiency.

FDA Approves Coagadex for Rare Clotting Disorder

First coagulation therapy sanctioned for Factor X deficiency
A checklist-based bedside physical examination in the intensive care unit is suggested as clinically useful in spite of a lack of evidence demonstrating this

Value of Bedside Exam for ICU Patients Discussed

Despite lack of evidence, authors recommend use of checklist-based bedside examination
Markets with greater increases in physician-hospital integration show greater increases in spending for outpatient care

Outpatient Spending Higher With Physician-Hospital Integration

Authors say increased spending attributable to price increases, not utilization changes
The American Cancer Society is delaying the recommended age when a woman should start receiving annual mammograms

ACS: Annual Mammograms Should Start at Age 45

Previous recommendation was 40; new guidelines place greater emphasis on approach of menopause
Praxbind (idarucizumab) has been approved for use in patients who are taking the anticoagulant Pradaxa (dabigatran) when there is an urgent need to reverse Pradaxa's anticoagulant effects

FDA Approves Praxbind to Reverse Pradaxa’s Effect

Praxbind cleared for emergency use with Pradaxa when bleeding can't be controlled
A large majority of older adults prefer to participate actively in health care decisions

Majority of Older Adults Want Active Role in Decision Making

More than two-thirds of older adults self-manage their health care activities
Excessive drinking cost the United States $249 billion -- $2.05 a drink -- in 2010

Excessive Drinking Cost U.S. $249 Billion in 2010

Most costs attributable to lower worker productivity, crime, treatment of health problems
In the Action to Control Cardiovascular Risk in Diabetes trial

Insulin Dose Doesn’t Up Mortality in ACCORD Trial

No significant association remained after adjustment for baseline covariates
Men's health supplements offer no benefit for patients with localized prostate cancer

ASTRO: Men’s Health Supplements No Use in Prostate CA

No reduction in risk of distant metastasis, cancer-related deaths, radiation-linked adverse effects
Longer QRS duration predicts cardiac death and nonfatal myocardial infarction in patients with coronary artery disease

Longer QRS Duration Predicts Cardiac Death, Heart Attack

Findings in patients with known, suspected coronary artery disease